Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Telomere shortening limits the number of cell divisions of primary human cells and might affect the regenerative capacity of organ systems during aging and chronic disease. To test whether the telomere hypothesis applies to human cirrhosis, the telomere length was monitored in cirrhosis induced by a broad variety of different etiologies. Telomeres were significantly shorter in cirrhosis compared with noncirrhotic samples independent of the primary etiology and independent of the age of the patients. Quantitative fluorescence in situ hybridization showed that telomere shortening was restricted to hepatocytes whereas lym‐phocytes and stellate cells in areas of fibrosis had significantly longer telomere reserves. Hepatocyte‐specific telomere shortening correlated with senescence‐associated p‐galactosidase staining in 84% of the cirrhosis samples, specifically in hepatocytes, but not in stellate cells or lymphocytes. Hepatocyte telomere shortening and senescence correlated with progression of fibrosis in cirrhosis samples. This study demonstrates for the first time that cell type‐specific telomere shortening and senescence are linked to progression of human cirrhosis. These findings give a novel explanation for the pathophysiology of cirrhosis, indicating that fibrotic scarring at the cirrhosis stage is a consequence of hepatocyte telomere shortening and senescence. The data imply that future therapies aiming to restore regenerative capacity during aging and chronic diseases will have to ensure efficient targeting of specific cell types within the affected organs.—Wiemann, S. U., Satyanarayana, A., Tsahuridu, M., Tillmann, H. L., Zender, L., Klempnauer, J., Flemming, P., Franco, S., Blasco, M. A., Manns, M. P., Rudolph, K. L. Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis. FASEB J. 16, 935–942 (2002)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Telomere shortening has been implicated in hepatocyte senescence94 and in disease progression in patients with liver cirrhosis95.”
From Telomere dysfunction in ageing and age-related diseases (2022) · cites this paper as [94]
In the citing paper
“Although less is known about hepatocyte senescence in humans than in mice, senescence-associated markers such as SA-β-gal staining have been identified in human cirrhotic livers160.”
From SenNet recommendations for detecting senescent cells in different tissues (2024) · cites this paper as [160]
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477 · cited 2×
“Senescence-associated -Gal staining was performed as described previously (18).”
BackgroundMethodTelomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750 · cited 1×
“Continuous shortening of telomeres during each cell division limits the life span of primary human cells in vitro (6).”
BackgroundHistological grading and staging of chronic hepatitis
Ishak, K., Baptista, A., Bianchi, L., Callea, F., De Groote, J., Gudat, F., Denk, H., Desmet, V., Korb, G., MacSween, R. N. M., et al. (1995) · Journal of Hepatology · doi:10.1016/0168-8278(95)80226-6 · Cited by 5,029 · cited 3×
“Cirrhosis samples were grouped into samples with mild fibrosis and samples with severe fibrosis according to the Ishak criteria (19).”
MethodInfluentialStructure and function of telomeres
Blackburn, E. H. (1991) · Nature · doi:10.1038/350569a0 · Cited by 3,596
The Cellular Basis of Hepatic Fibrosis -- Mechanisms and Treatment Strategies
Flier, J. S., Underhill, L. H., & Friedman, S. L. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306243282508 · Cited by 1,432
p53- and ATM-Dependent Apoptosis Induced by Telomeres Lacking TRF2
Karlseder, J., Broccoli, D., Dai, Y., Hardy, S., & de Lange, T. (1999) · Science · doi:10.1126/science.283.5406.1321 · Cited by 1,086 · cited 1×
“The tumor suppressor p53 has been identified as a downstream target of short dysfunctional telomeres in mouse (34) and human cells (35).”
BackgroundChin, L., Artandi, S. E., Shen, Q., Tam, A., Lee, S.-L., Gottlieb, G. J., Greider, C. W., & DePinho, R. A. (1999) · Cell · doi:10.1016/s0092-8674(00)80762-x · Cited by 979
Telomere Shortening Is Associated with Cell Division in Vitro and in Vivo
Allsopp, R. C., Chang, E., Kashefi-Aazam, M., Rogaev, E. I., Piatyszek, M. A., Shay, J. W., & Harley, C. B. (1995) · Experimental Cell Research · doi:10.1006/excr.1995.1306 · Cited by 533 · cited 2×
“It is still a matter of debate to what extent telomere shortening affects organo-pathophysiology during aging (7) or chronic diseases that induce elevated rates of cell turnover (8–11).”
BackgroundTelomere dysfunction and evolution of intestinal carcinoma in mice and humans
Rudolph, K. L., Millard, M., Bosenberg, M. W., & DePinho, R. A. (2001) · Nature Genetics · doi:10.1038/88871 · Cited by 527 · cited 1×
“It has been shown that telomere shortening inhibits tumorigenesis in mTERC / mice that retain functional p53 (17, 32, 33).”
BackgroundSelf-citationCurrent Protocols in Cell Biology
(2001) · John Wiley & Sons, Inc. eBooks · doi:10.1002/0471143030 · Cited by 502
Research works printed but not linked: 1
- Rudolph K. L., 2001, Telomeres and telomerase in experimental liver cirrhosis, The Liver Biology and Pathobiology, 1000
Cited by
Items 201–300 of 547
Telomeres And Telomerase in Adult Stem Cells and Pluripotent Embryonic Stem Cells
Marión, R. M., & Blasco, M. A. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-7037-4_9 · Cited by 52
Self-citationLipid droplets, autophagy, and ageing: A cell-specific tale
Maestri, A., Garagnani, P., Pedrelli, M., Hagberg, C. E., Parini, P., & Ehrenborg, E. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102194 · Cited by 48
“…and functionality, increased senescence and decreased auto-phagy, which results in the accumulation of protein aggregates like Mallory-Denk bodies and lipofuscin and reduced lipid buffering activity (Allaire and Gilgenkrantz, 2020; Hunt et al., 2019; Stumptner et al., 2002; Wiemann et al., 2002).”
Lechel, A., Manns, M. P., & Rudolph, K. L. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.06.010 · Cited by 47
“[50] Wiemann SU, Satyanarayana A, Tsahuridu M, Tillmann HL, Zender”
BackgroundInfluentialSelf-citationAutophagy and senescence: the molecular mechanisms and implications in liver diseases
Li, Q., Lin, Y., Liang, G., Xiao, N., Zhang, H., Yang, X., Yang, J., & Liu, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316880 · Cited by 43
“Liver cirrhosis development is related to hepatocyte senescence [154].”
BackgroundMolecular Targets in Hepatocarcinogenesis and Implications for Therapy
Wu, M., Yiang, G.-T., Cheng, P., Chu, P., & Li, C.-J. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7080213 · Cited by 45
“Notably, mutations in the TERT gene represent the most common mutation in HCC, leading to increased TERT transcript expression Accordingly, many studies have investigated telomerase complex dysfunction, which promotes the development of hepatocarcinogenesis [20,21].”
BackgroundLoss of hepatocyte cell division leads to liver inflammation and fibrosis
Dewhurst, M. R., Ow, J. R., Zafer, G., van Hul, N. K. M., Wollmann, H., Bisteau, X., Brough, D., Choi, H., & Kaldis, P. (2020) · PLOS Genetics · doi:10.1371/journal.pgen.1009084 · Cited by 42
Cellular senescence in liver diseases: From molecular drivers to therapeutic targeting
Du, K., Umbaugh, D. S., Ren, N., & Diehl, A. M. (2025) · Journal of Hepatology · doi:10.1016/j.jhep.2025.08.021 · Cited by 47
Möller, P., Wils, R. S., Jensen, D. M., Andersen, M. H. G., & Roursgaard, M. (2018) · Critical Reviews in Toxicology · doi:10.1080/10408444.2018.1538201 · Cited by 45
“Studies also indicate agedependent telomere shortening in the lungs (Everaerts et al. 2018), liver (Aikata et al. 2000; Wiemann et al. 2002), muscle, skin and fat tissues of humans (Daniali et al. 2013).”
BackgroundTelomere dysfunction and stem cell ageing
Ju, Z., & Rudolph, K. L. (2007) · Biochimie · doi:10.1016/j.biochi.2007.09.006 · Cited by 48
Self-citationHepatitis B Virus Treatment and Hepatocellular Carcinoma: Controversies and Approaches to Consensus
Kim, S. K., Fujii, T., Kim, S. R., Nakai, A., Lim, Y., Hagiwara, S., & Kudo, M. (2022) · Liver Cancer · doi:10.1159/000525518 · Cited by 42
Kim, D., Li, A. A., & Ahmed, A. (2018) · Liver International · doi:10.1111/liv.13886 · Cited by 43
Haque, E., Karim, M. R., Teeli, A. S., Śmiech, M., Leszczyński, P., Winiarczyk, D., Parvanov, E. D., Atanasov, A. G., & Taniguchi, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155378 · Cited by 40
Cellular senescence in liver fibrosis: Implications for age-related chronic liver diseases
Udomsinprasert, W., Sobhonslidsuk, A., Jittikoon, J., Honsawek, S., & Chaikledkaew, U. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1992385 · Cited by 40
“Similarly, a prior study by Wiemann et al [89]. has revealed that hepatocyte telomere shortening and senescence were directly correlated with the progression of liver fibrosis in human cirrhosis samples.”
ResultCellular Senescence in Livers from Children with End Stage Liver Disease
Gutierrez-Reyes, G., Garcia de Leon, M. D. C., Varela-Fascinetto, G., Valencia, P., Pérez Tamayo, R., Rosado, C. G., Labonne, B. F., Rochilin, N. M., Garcia, R. M., Valadez, J. A., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010231 · Cited by 40
Zaidi, M. R., & Liebermann, D. A. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-94804-7_8 · Cited by 49
Sirma, H., Kumar, M., Meena, J. K., Witt, B., Weise, J. M., Lechel, A., Ande, S., Sakk, V., Guguen‐Guillouzo, C., Zender, L., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.03.047 · Cited by 41
Self-citationNishikawa, T., Nakajima, T., Katagishi, T., Okada, Y., Jo, M., Kagawa, K., Okanoue, T., Itoh, Y., & Yoshikawa, T. (2009) · Liver International · doi:10.1111/j.1478-3231.2008.01963.x · Cited by 41
Telomere length regulation during cloning, embryogenesis and ageing
Schaetzlein, S., & Rudolph, K. L. (2004) · Reproduction Fertility and Development · doi:10.1071/rd04112 · Cited by 43
Self-citationThe aged liver: Beyond cellular senescence
Allaire, M., & Gilgenkrantz, H. (2019) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2019.07.011 · Cited by 41
Jannone, G., Rozzi, M., Najimi, M., Decottignies, A., & Sokal, E. M. (2020) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155420913534 · Cited by 40
Uysal, F., Kosebent, E. G., Toru, H. S., & Öztürk, S. (2020) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-020-01932-1 · Cited by 40
DeFilippis, R. A., Fordyce, C., Patten, K. T., Chang, H., Zhao, J., Fontenay, G., Kerlikowske, K. M., Parvin, B., & Tlsty, T. D. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3390 · Cited by 38
Manco, R., Leclercq, I. A., & Clerbaux, L.-A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19124115 · Cited by 36
“In such an environment, hepatocytes are not able to proliferate anymore and may thus enter into replicative senescence [62,63].”
BackgroundCellular senescence in liver diseases: From mechanisms to therapies
Ge, T., Shao, Y., Bao, X., Xu, W., & Lu, C. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110522 · Cited by 38
Lee, Y., & Friedman, S. L. (2010) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385233-5.00006-4 · Cited by 41
Cardiac-Referenced Leukocyte Telomere Length and Outcomes After Cardiovascular Surgery
Yin, H. R., Akawi, O., Fox, S. A., Li, F., O’Neil, C. H., Balint, B., Arpino, J., Watson, A., Wong, J. A., Guo, L.-R. R., et al. (2018) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2018.07.004 · Cited by 36
“Although the TL of atrial fibroblasts versus cardiomyocytes is unknown, fibroblast-like cells in liver were found to have longer telomeres than parenchymal cells (37).”
BackgroundSphingolipids at the Crossroads of NAFLD and Senescence
Nikolova‐Karakashian, M. (2018) · Advances in cancer research · doi:10.1016/bs.acr.2018.05.002 · Cited by 39
Cell intrinsic and extrinsic mechanisms of stem cell aging depend on telomere status
Song, Z., Ju, Z., & Rudolph, K. L. (2008) · Experimental Gerontology · doi:10.1016/j.exger.2008.06.009 · Cited by 38
Self-citationBaliou, S., Ιωάννου, Π., Apetroaei, M.-M., Vakonaki, E., Fragkiadaki, P., Kirithras, E., Tzatzarakis, M. N., Arsene, A. L., Docea, A. O., & Tsatsakis, A. M. (2024) · Nutrients · doi:10.3390/nu16152525 · Cited by 34
van Steenbeek, F. G., den Bossche, L. V., Leegwater, P. A. J., & Rothuizen, J. J. (2011) · Mammalian Genome · doi:10.1007/s00335-011-9364-0 · Cited by 41
Bone marrow derived stem cells for the treatment of end-stage liver disease.
Margini, C., Vukotic, R., Brodosi, L., Bernardi, M., & Andreoné, P. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i27.9098 · Cited by 36
Brown, K. E., Mathahs, M. M., Broadhurst, K. A., Coleman, M. C., Ridnour, L. A., Schmidt, W. N., & Spitz, D. R. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.10.039 · Cited by 33
The impact of aging on liver health and the development of liver diseases
Williams, S. N., & Ding, W. (2025) · Hepatology Communications · doi:10.1097/hc9.0000000000000808 · Cited by 35
“[31] Hepatocyte polyploidy, decreased telomere length, and hypertrophy were observed in hepatocytes from aged rodent livers and human hepatocytes.”
Hepatic regeneration and the epithelial to mesenchymal transition
Xue, Z., Wu, X., & Liu, M. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i9.1380 · Cited by 35
Molecular Pathogenesis and Targeted Therapy of Hepatocellular Carcinoma
Zender, L., & Kubicka, S. (2008) · Onkologie · doi:10.1159/000151586 · Cited by 36
Self-citationAging reduces liver resiliency by dysregulating Hedgehog signaling
Maeso‐Díaz, R., Dalton, G. D., Oh, S., Du, K., Tang, L., Chen, T., Dutta, R. K., Hartman, J. H., Meyer, J. N., & Diehl, A. M. (2022) · Aging Cell · doi:10.1111/acel.13530 · Cited by 32
Stem Cell Therapy for Digestive Tract Diseases: Current State and Future Perspectives
Trébol, J., Georgiev-Hristov, T., García‐Arranz, M., & García‐Olmo, D. (2010) · Stem Cells and Development · doi:10.1089/scd.2010.0277 · Cited by 33
Brunt, E. M., Walsh, S. N., Hayashi, P. H., LaBundy, J., & Di Bisceglie, A. M. (2007) · Liver International · doi:10.1111/j.1478-3231.2007.01470.x · Cited by 32
Anatomy, pathophysiology and basic mechanisms of disease
Crawford, J. M., & Burt, A. D. (2011) · Elsevier eBooks · doi:10.1016/b978-0-7020-3398-8.00001-5 · Cited by 33
Effects of apoptosis on liver aging
Hu, S., Jiang, S., Zhang, J., Luo, D., Yu, B., Yang, L.-Y., Zhong, H., Yang, M.-W., Liu, L.-Y. D., Hong, F., et al. (2019) · World Journal of Clinical Cases · doi:10.12998/wjcc.v7.i6.691 · Cited by 33
Ow, J. R., Caldez, M. J., Zafer, G., Foo, J. C., Li, H. Y., Ghosh, S., Wollmann, H., Cazenave‐Gassiot, A., Ong, C. B., Wenk, M. R., et al. (2020) · eLife · doi:10.7554/elife.63835 · Cited by 31
Telomere Dysfunction and DNA Damage Checkpoints in Diseases and Cancer of the Gastrointestinal Tract
Rudolph, K. L., Hartmann, D., & Opitz, O. G. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.07.037 · Cited by 33
Self-citationCellular Senescence in Hepatocellular Carcinoma: The Passenger or the Driver?
Cai, X., Guillot, A., & Liu, H. (2022) · Cells · doi:10.3390/cells12010132 · Cited by 36
“, that the fibrotic scarring at the cirrhosis stage is a consequence of hepatocyte telomere shortening and senescence, which also implies that hepatocellular senescence is a promising marker of cirrhosis [35].”
BackgroundAlves‐Paiva, R. M., Kajigaya, S., Feng, X., Chen, J., Desierto, M. J., Wong, S. C., Townsley, D. M., Donaires, F. S., Bertola, A., Gao, B., et al. (2017) · Liver International · doi:10.1111/liv.13529 · Cited by 30
SMARCD1 regulates senescence-associated lipid accumulation in hepatocytes
Inoue, C., Zhao, C., Tsuduki, Y., Udono, M., Wang, L., Nomura, M., & Katakura, Y. (2017) · npj Aging and Mechanisms of Disease · doi:10.1038/s41514-017-0011-1 · Cited by 31
Güneş, Ç., Avila, A. I., & Rudolph, K. L. (2017) · Differentiation · doi:10.1016/j.diff.2017.12.004 · Cited by 30
Self-citationRelationship between Telomere Maintenance and Liver Disease
Barnard, A., Moch, A., & Saab, S. (2018) · Gut and Liver · doi:10.5009/gnl18081 · Cited by 30
“This telomere shortening and senescence have been linked to the progression of fibrosis proposing a causative role.(14) Clinically this has been observed in the context of hepatitis C viral infection (HCV).”
BackgroundAsbestos and Intrahepatic Cholangiocarcinoma
Brandi, G., & Tavolari, S. (2020) · Cells · doi:10.3390/cells9020421 · Cited by 29
“In these circumstances, the regenerative capability of hepatocytes and cholangiocytes is lost or significantly impaired, due to necrosis/apoptosis or replicative senescence, this last resulting from the continuous turnover over 20–30 years of chronic liver disease, that gradually leads to telomere shortening in these…”
BackgroundAssociation between telomere length and hepatic fibrosis in non-alcoholic fatty liver disease
Shin, H. K., Park, J. H., Yu, J. H., Jin, Y., Suh, Y. J., Lee, J., Kim, W. K., & The Korean Nonalcoholic Fatty Liver Study Group (KNSG) (2021) · Scientific Reports · doi:10.1038/s41598-021-97385-2 · Cited by 31
Akiba, J., Murakami, Y., Noda, M., Watari, K., Ogasawara, S., Yoshida, T., Kawahara, A., Sanada, S., Yasumoto, M., Yamaguchi, R., et al. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.05.034 · Cited by 28
“Several studies have documented the intranuclear p21 in senescent hepatocytes in many forms of chronic liver disease [26–30].”
BackgroundMolecular Mechanisms to Target Cellular Senescence in Hepatocellular Carcinoma
Mittermeier, C., Konopa, A., & Muehlich, S. (2020) · Cells · doi:10.3390/cells9122540 · Cited by 30
Giannakoulis, V. G., Dubovan, P., Papoutsi, E., Kataki, A., & Koskinas, J. S. (2021) · Cancers · doi:10.3390/cancers13184732 · Cited by 29
“Finally, the HBx protein has been implicated in telomere shortening [57], which leads to hepatocellular senescence and consequently the development of cirrhosis [58].”
BackgroundSenescence Connects Autophagy Deficiency to Inflammation and Tumor Progression in the Liver
Huda, N., Khambu, B., Liu, G., Nakatsumi, H., Yan, S., Chen, X., Ma, M., Dong, Z., Nakayama, K. I., & Yin, X. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.04.003 · Cited by 28
Cell transplantation-based regenerative medicine in liver diseases
Cardinale, V., Lanthier, N., Baptista, P. M., Carpino, G., Carnevale, G., Orlando, G., Angelico, R., Manzia, T. M., Schuppan, D., Pinzani, M., et al. (2023) · Stem Cell Reports · doi:10.1016/j.stemcr.2023.06.005 · Cited by 33
Delladetsima, J. K., Alexandrou, P. T., Giaslakiotis, K., Psichοgiou, M., Hatzis, G. S., Sypsa, V., & TINIAKOS, D. G. (2010) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-010-0957-x · Cited by 30
The association between telomere length and non-alcoholic fatty liver disease: a prospective study
Tang, L., Li, D., Ma, Y., Cui, F., Wang, J., & Tian, Y. (2023) · BMC Medicine · doi:10.1186/s12916-023-03136-7 · Cited by 31
“Population-based research has also found that patients with more advanced stages of liver cirrhosis tended to have shorter TL [41].”
MethodPacheco-Rivera, R., Fattel‐Fazenda, S., Arellanes‐Robledo, J., Silva-Olivares, A., Alemán‐Lazarini, L., Rodríguez‐Segura, M. A., Pérez‐Carreón, J. I., Villa‐Treviño, S., Shibayama, M., & Serrano‐Luna, J. (2015) · Toxicology Letters · doi:10.1016/j.toxlet.2015.11.011 · Cited by 27
Ninjurin1 increases p21 expression and induces cellular senescence in human hepatoma cells
Toyama, T., Sasaki, Y., Horimoto, M., Iyoda, K., Yakushijin, T., Ohkawa, K., Takehara, T., Kasahara, A., Araki, T., Hori, M., et al. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.06.027 · Cited by 26
“In fact, senescent cells accumulate in chronic hepatitis, probably due to repeated destruction and regeneration of hepatocytes, and further increase in HCC tissue [12,24].”
BackgroundRole of senescent fibroblasts on alkali‐induced corneal neovascularization
Zhou, Q., Yang, L., Qu, M., Wang, Y., Chen, P., Wang, Y., & Shi, W. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22835 · Cited by 27
“…2008), kidney fibrosis (Ding et al., 2001) and transplantation (Melk et al., 2009), biliary cirrhosis (Sasaki et al., 2005), hepatic cirrhosis (Wiemann et al., 2002; Krizhanovsky et al., 2008), osteoarthritis (Martin and Buckwalter, 2003), and other chronic wounds (Vande Berg et al., 1998;…”
BackgroundJang, S., Lee, J. M., Lee, D. H., Joo, I., Yoon, J. H., Chang, W., & Han, J. K. (2016) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.25517 · Cited by 26
Telomere Length in Peripheral Blood Leukocytes Is Associated with Severity of Biliary Atresia
Udomsinprasert, W., Poovorawan, Y., Chongsrisawat, V., Vejchapipat, P., Zhan, D., & Honsawek, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134689 · Cited by 25
Liver damage and senescence increases in patients developing hepatocellular carcinoma
Rey, S., Quintavalle, C., Burmeister, K., Calabrese, D., Schlageter, M., Quagliata, L., Cathomas, G., Diebold, J., Molinolo, A. A., Heim, M. H., et al. (2017) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13717 · Cited by 27
Correlation Between Liver Fibrosis and Inflammation in Patients Transplanted for HCV Liver Disease
Baiocchi, L., Angelico, M., Petrolati, A., Perrone, L., Palmieri, G., Battista, S., Carbone, M., Tariciotti, L., Longhi, C., Orlando, G., et al. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2007.02107.x · Cited by 25
Immunotherapy, targeted therapy, and their cross talks in hepatocellular carcinoma
Liu, J., Park, K., Shen, Z., Lee, H. M., Geetha, P., Pakyari, M., & Chai, L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1285370 · Cited by 25
Aini, W., Miyagawa‐Hayashino, A., Tsuruyama, T., Hashimoto, S., Sumiyoshi, S., Ozeki, M., Tamaki, K., Üemoto, S., & Haga, H. (2012) · Transplant International · doi:10.1111/j.1432-2277.2012.01523.x · Cited by 25
REVIEWS IN BASIC AND CLINICAL GASTROENTEROLOGY
Lynch, J. P., Metz, D. C., Schuppan, D., Junker, Y., & Barisani, D. (2009) · Cited by 24
Raman fingerprints as promising markers of cellular senescence and aging
Liendl, L., Grillari, J., & Schosserer, M. (2019) · GeroScience · doi:10.1007/s11357-019-00053-7 · Cited by 24
“…and occur predominantly at sites of age-associated pathologies, which include atherosclerosis (Erusalimsky and Kurz 2005; Gorenne et al. 2006; Minamino 2002; Vasile et al. 2001), osteoporosis (Kassem and Marie 2011), neuroinflammation (Bitto et al. 2010), and liver cirrhosis (Wiemann et al. 2002).”
BackgroundSenescence: Not Just for Tumor Suppression
Green, M. R. (2008) · Cell · doi:10.1016/j.cell.2008.08.003 · Cited by 28
“Although senescent cells had been detected in cirrhotic human liver in other studies, these cells were thought to be hepatocytes (Wiemann et al., 2002).”
BackgroundWiemann, S. U., Ande, S., Buer, J., Kamino, K., Manns, M. P., & Rudolph, K. L. (2004) · Oncogene · doi:10.1038/sj.onc.1208308 · Cited by 24
Self-citationTelomeres do the (un)twist: Helicase actions at chromosome termini
Chavez, A., Tsou, A. M., & Johnson, F. B. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.02.008 · Cited by 25
Role of cellular senescence in hepatic wound healing and carcinogenesis
Ramakrishna, G., Anwar, T., Angara, R. K., Chatterjee, N., Kiran, S., & Singh, S. (2012) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2012.08.002 · Cited by 23
Telomeres: Dysfunction, Maintenance, Aging and Cancer
Liao, P., Yan, B., Wang, C., & Lei, P. (2023) · Aging and Disease · doi:10.14336/ad.2023.1128 · Cited by 36
The Study on Telomere Length for Age Estimation in a Thai Population
Srettabunjong, S., Satitsri, S., Thongnoppakhun, W., & Tirawanchai, N. (2014) · American Journal of Forensic Medicine & Pathology · doi:10.1097/paf.0000000000000095 · Cited by 24
Sharma, S., Maras, J. S., Das, S., Hussain, S., Mishra, A. K., Shasthry, S. M., Sharma, C. B., Weiss, E., Elkrief, L., Rautou, P., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-07161-4 · Cited by 22
Telomerase mutation: A genetic risk factor for cirrhosis
Chaiteerakij, R., & Roberts, L. R. (2011) · Hepatology · doi:10.1002/hep.24304 · Cited by 22
The context-dependent effect of cellular senescence: From embryogenesis and wound healing to aging
Lavarti, R., Alvarez-Diaz, T., Marti, K., Kar, P., & Raju, R. P. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102760 · Cited by 21
Sen, B., Aggarwal, S., Nath, R., Sehgal, R., Singh, R., Agrawal, K., Shashidhara, A. N., Rastogi, A., Bajpai, M., Pamecha, V., et al. (2022) · Medical Oncology · doi:10.1007/s12032-022-01732-w · Cited by 24
Is the liver resilient to the process of ageing?
Chatterjee, N., Sharma, R., Kale, P. R., Trehanpati, N., & Ramakrishna, G. (2024) · Annals of Hepatology · doi:10.1016/j.aohep.2024.101580 · Cited by 27
“…cytokine storm due to liver injury [73], (b) telomere shortening and features of cellular senescence in hepatocytes and cholangiocytes in cirrhosis [74-76], (c) immunese-nescence of the liver resident and in fi ltrating immune cells by viruses [77] (d) changes in gut microbiota which in turn can in…”
Resistin impairs SIRT1 function and induces senescence-associated phenotype in hepatocytes
An, Y., Zheng, Y., Zhang, R., Huang, J., Zhu, Z., Zhou, R., Jin, D., & Yang, Z. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.06.028 · Cited by 23
“…there is an increase in the number of liver cells staining positive for SA-b-Gal (senescence-associated b-galactosidase activity) in patients with cirrhotic livers (Wiemann et al., 2002) and resistin serum levels were significantly elevated in patients with liver cirrhosis (Yagmur et al., 2006).”
BackgroundXiao, M., Chen, W., Wang, C., Wu, Y., Zhu, S., Zeng, C., Cai, Y., Liu, C., & He, Z. (2017) · Oncotarget · doi:10.18632/oncotarget.23622 · Cited by 21
Senescence of activated stellate cells: Not just early retirement†
Schrader, J., Fallowfield, J., Iredale, J. P., Kowdley, K., McCaughan, G., & Trautwein, C. (2009) · Hepatology · doi:10.1002/hep.22832 · Cited by 21
Hepatocellular Telomere Length in Biliary Atresia Measured by Q‐FISH
Sanada, Y., Aida, J., Kawano, Y., Nakamura, K., Shimomura, N., Ishikawa, N., Arai, T., Poon, S. S. S., Yamada, N., Okada, N., et al. (2012) · World Journal of Surgery · doi:10.1007/s00268-012-1453-z · Cited by 21
Stem cell ageing: does it happen and can we intervene?
Bellantuono, I., & Keith, W. N. (2007) · Expert Reviews in Molecular Medicine · doi:10.1017/s146239940700049x · Cited by 24
Pang, X., Gao, S., Liu, T., Xu, F. X., Chang, F., Zhang, J. F., & Jiang, H. (2024) · Genomics · doi:10.1016/j.ygeno.2024.110800 · Cited by 20
Cancer-Associated Mutations in Healthy Individuals: Assessing the Risk of Carcinogenesis
Rodriguez-Brenes, I. A., Komarova, N. L., & Wodarz, D. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-1452 · Cited by 21
“2014 AACR.”
Marongiu, F., Serra, M. P., Sini, M., Angius, F., & Laconi, E. (2014) · Aging · doi:10.18632/aging.100631 · Cited by 21
Munroe, M., Niero, E. L. D. O., Fok, W. C., Vessoni, A. T., Jeong, H., Brenner, K. A., & Batista, L. F. Z. (2020) · Hepatology · doi:10.1002/hep.31414 · Cited by 21
Accelerated telomere reduction and hepatocyte senescence in tolerated human liver allografts
Aini, W., Miyagawa‐Hayashino, A., Ozeki, M., Salah, A., Hirata, M., Tamaki, K., Üemoto, S., & Haga, H. (2014) · Transplant Immunology · doi:10.1016/j.trim.2014.06.008 · Cited by 22
The Role of Cellular Senescence in the Gastrointestinal Mucosa
Penfield, J. D., Anderson, M. A., Lutzke, L. L., & Wang, K. K. (2013) · Gut and Liver · doi:10.5009/gnl.2013.7.3.270 · Cited by 22
Sasaki, M., & Nakanuma, Y. (2011) · International Journal of Hepatology · doi:10.1155/2012/452143 · Cited by 19
Proliferative drive and liver carcinogenesis: Too much of a good thing?
Teoh, N. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.06121.x · Cited by 28
Kawano, Y., Ishikawa, N., Aida, J., Sanada, Y., Izumiyama‐Shimomura, N., Nakamura, K., Poon, S. S. S., Matsumoto, K., Mizuta, K., Uchida, E., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093749 · Cited by 19
Viswanathan, P., Sharma, Y., Maisuradze, L., Tchaikovskaya, T. L., & Gupta, S. K. (2020) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2020.104369 · Cited by 20
“Such perturbations have been of significance for attenuating hepatic replication in cell transplantation assays [51], as well as ALF or chronic liver disease [9, 52].”
BackgroundCellular senescence in vivo: From cells to tissues to pathologies
Kumar, A., Bano, D., & Ehninger, D. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111308 · Cited by 20
Chang, T., Yang, Y., Chen, W., Shen, C., Tung, S., Yen, C., Hsieh, Y., Lee, C.-P., Tsai, M.-L., Hung, C., et al. (2021) · Scientific Reports · doi:10.1038/s41598-020-80523-7 · Cited by 20
Pan, C. C., Maeso‐Díaz, R., Lewis, T. R., Xiang, K., Tan, L., Liang, Y., Wang, L., Yang, F., Yin, T., Wang, C., et al. (2023) · Cell Research · doi:10.1038/s41422-023-00820-4 · Cited by 20
Wan, S., HANN, H.-W. L., Myers, R. E., Fu, X., Hann, R. S., Kim, S. H., Tang, H. Y., Xing, J., & Yang, H. (2012) · Liver International · doi:10.1111/j.1478-3231.2012.02801.x · Cited by 19
Two-tier regenerative response in liver failure in humans
Rastogi, A., Maiwall, R., Bihari, C., Trehanpati, N., Pamecha, V., & Sarin, S. K. (2014) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-014-1547-0 · Cited by 21
“The study of advanced cirrhosis in humans and chronic liver injury in mice has provided evidence that replicative activity of hepatocytes diminishes, leading to a state of “replicative senescence” [28–33].”
BackgroundChoi, J., Kim, J. K., Yang, Y. J., Kim, Y., Kim, P., Park, S. G., Cho, E. Y., Lee, D. H., & Choi, J. W. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.10.002 · Cited by 19
Hematological Abnormalities in Cirrhosis: A Narrative Review
Lingas, E. C. (2023) · Cureus · doi:10.7759/cureus.39239 · Cited by 31
“Recent studies discovered that hepatocyte telomere shortening and senescence may lead to progressive scarring of liver tissues leading to fibrosis and ultimately cirrhosis [32].”
Background
Metadata
- Authors
- WIEMANN, S. U., SATYANARAYANA, A., TSAHURIDU, M., TILLMANN, H. L., ZENDER, L., KLEMPNAUER, J., FLEMMING, P., FRANCO, S., BLASCO, M. A., MANNS, M. P., & RUDOLPH, K. L.
- Affiliations
- Medizinische Hochschule Hannover (DE)
- Department of Gastroenterology, Hepatology, and Endocrinology Medical School Hannover Germany
- Consejo Superior de Investigaciones Científicas (ES)
- Department of Immunology and Oncology Centro National de Biotecnologia/CSIC Madrid Spain
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2002-07
- Volume
- 16
- Issue
- 9
- Pages
- 935-942
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2166704790
- Cited by
- 527
- References
- 34
- Citations by year
- 2026: 4 · 2025: 15 · 2024: 22 · 2023: 23 · 2022: 20 · 2021: 28 · 2020: 35 · 2019: 17 · 2018: 29 · 2017: 22 · 2016: 24 · 2015: 18 · 2014: 30 · 2013: 20 · 2012: 20
- FWCI
- 7.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft (Ru 745/2-1, SFB 265/C5)
- Deutsche Krebshilfe (10-1809-Ru1)
- Ministerio de Ciencia y Tecnología
- European Commission
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Keywords
- telomere shortening, hepatocyte senescence, liver cirrhosis, liver fibrosis, senescence-associated β-galactosidase, hepatocytes, hepatic stellate cells, lymphocytes, telomere length, cirrhosis progression, regenerative capacity, aging
- MeSH terms
- Adolescent, Adult, Age Factors, Aged, beta-Galactosidase, Child, Humans, Liver Cirrhosis, Middle Aged, Models, Biological, Biomarkers, Telomere, Cellular Senescence, Disease Progression, Hepatocytes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.